Proliferative and necrotising otitis externa (PNOE) is a very rare disease affecting the ear canals and concave pinnae of kittens. This report describes a 5-month-old cat with PNOE. Histopathological examination confirmed the diagnosis. Treatment was initiated with local injection of methylprednisolone acetate into the lesions. The cat was subsequently treated with clobetasol propionate cream, a potent topical glucocorticoid ointment. The cat showed marked improvement. While topical treatment with tacrolimus, an immunosuppressive agent, is reported to be an effective therapy, to the best of our knowledge, this is the first report to treat PNOE with local corticosteroid therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240769 | PMC |
http://dx.doi.org/10.1292/jvms.15-0652 | DOI Listing |
Laryngoscope Investig Otolaryngol
December 2024
Division of Otology, Neurotology and Cranial Base Surgery, Department of Otolaryngology-Head and Neck Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA.
Objective: Malignant otitis externa (MOE) is typically managed with long-term broad-spectrum antibiotics. The impact of surgical intervention on clinical outcomes is not well described. This study aims to compare clinical outcomes of MOE patients managed with or without surgery.
View Article and Find Full Text PDFCanine Malassezia dermatitis (CMD) and otitis externa are generally treated by antifungal drugs. However, azole-resistant strains have been isolated from canine skin and ear canals worldwide. Phytochemicals isolated from essential oils are effective alternatives for inhibiting Malassezia pachydermatis.
View Article and Find Full Text PDFActa Otolaryngol
December 2024
ENT Department, Queen's Medical Centre, Nottingham, UK.
Background: Recurrence rate of necrotising otitis externa (NOE) after treatment is 15-20%. This is mainly due to a lack of reliable clinical indicator for the resolution of disease.
Aims: We aim to assess the predictability of the otalgia, otorrhoea and C-reactive protein (CRP) levels in a large cohort of sixty-two patients for treatment outcome.
Aust J Gen Pract
December 2024
MBBS, FRACS, ENT Consultant, Surgical Treatment and Rehabilitation Service (STARS), Brisbane, Qld.
Background: Acute otitis externa (AOE) is an inflammatory condition of the outer ear seen in Australian general practice and is prevalent in tropical climates like North Queensland.
Objective: This article aims to delineate key facets of AOE, identify high-risk populations and propose a streamlined management approach aligned with the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNS) guideline, emphasising the role of primary care in optimal patient care.
Discussion: Outlined within this article are key elements of AOE, from anatomy to risk factors, examination, diagnosis, differentials, management, prevention and indications for referral.
Eur Arch Otorhinolaryngol
November 2024
Department of Otorhinolaryngology, Duesseldorf University Hospital, Moorenstrasse 5, 40225, Duesseldorf, Germany.
Introduction: Skull base osteomyelitis is a rare but potentially life-threatening disease. It usually occurs as a complication of severe otitis externa or infection in the nasopharynx, often in immunocompromised patients. The therapeutic strategy is complex, patient-specific and requires interdisciplinary cooperation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!